Search research articles
Contact Us
Filters
Showing results (51-60 of 61) with videos related to
Page
of 7
Sort By:
Blood
|
February 11, 2020
Selective inhibition of Ph-positive ALL cell growth through kinase-dependent and -independent effects by CDK6-specific PROTACs
Marco De Dominici, Patrizia Porazzi, Youcai Xiao, et al.
Nature Communications
|
November 10, 2021
Inability to switch from ARID1A-BAF to ARID1B-BAF impairs exit from pluripotency and commitment towards neural crest formation in ARID1B-related neurodevelopmental disorders
Luca Pagliaroli, Patrizia Porazzi, Alyxandra T Curtis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 4, 2008
Impact of a single nucleotide polymorphism in the MDM2 gene on neuroblastoma development and aggressiveness: results of a pilot study on 239 patients
Sara Cattelani, Raffaella Defferrari, Sonia Marsilio, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
November 21, 2018
Semaphorin 5A drives melanoma progression: role of Bcl-2, miR-204 and c-Myb
Simona D'Aguanno, Elisabetta Valentini, Maria Grazia Tupone, et al.
Cancer Research
|
December 14, 2021
Targeting Chemotherapy to Decondensed H3K27me3-Marked Chromatin of AML Cells Enhances Leukemia Suppression
Patrizia Porazzi, Svetlana Petruk, Luca Pagliaroli, et al.
The Journal of Clinical Investigation
|
April 14, 2009
Targeting autophagy potentiates tyrosine kinase inhibitor-induced cell death in Philadelphia chromosome-positive cells, including primary CML stem cells
Cristian Bellodi, Maria Rosa Lidonnici, Ashley Hamilton, et al.
Neoplasia (New York, N.Y.)
|
August 21, 2012
The p53 codon 72 Pro/Pro genotype identifies poor-prognosis neuroblastoma patients: correlation with reduced apoptosis and enhanced senescence by the p53-72P isoform
Sara Cattelani, Giovanna Ferrari-Amorotti, Sara Galavotti, et al.
Journal of the National Cancer Institute
|
November 23, 2017
Targeting BCR-ABL-Independent TKI Resistance in Chronic Myeloid Leukemia by mTOR and Autophagy Inhibition
Rebecca Mitchell, Lisa E M Hopcroft, Pablo Baquero, et al.
Molecular Cancer Therapeutics
|
May 31, 2015
Structure-Based Screen Identifies a Potent Small Molecule Inhibitor of Stat5a/b with Therapeutic Potential for Prostate Cancer and Chronic Myeloid Leukemia
Zhiyong Liao, Lei Gu, Jenny Vergalli, et al.
Blood Cancer Discovery
|
September 25, 2020
Persistence of Drug-Resistant Leukemic Stem Cells and Impaired NK Cell Immunity in CML Patients Depend on <i>MIR300</i> Antiproliferative and PP2A-Activating Functions
Giovannino Silvestri, Rossana Trotta, Lorenzo Stramucci, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 61) with videos related to
Sort By:
Page
of 7
Blood
|
February 11, 2020
Selective inhibition of Ph-positive ALL cell growth through kinase-dependent and -independent effects by CDK6-specific PROTACs
Marco De Dominici, Patrizia Porazzi, Youcai Xiao, et al.
Nature Communications
|
November 10, 2021
Inability to switch from ARID1A-BAF to ARID1B-BAF impairs exit from pluripotency and commitment towards neural crest formation in ARID1B-related neurodevelopmental disorders
Luca Pagliaroli, Patrizia Porazzi, Alyxandra T Curtis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 4, 2008
Impact of a single nucleotide polymorphism in the MDM2 gene on neuroblastoma development and aggressiveness: results of a pilot study on 239 patients
Sara Cattelani, Raffaella Defferrari, Sonia Marsilio, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
November 21, 2018
Semaphorin 5A drives melanoma progression: role of Bcl-2, miR-204 and c-Myb
Simona D'Aguanno, Elisabetta Valentini, Maria Grazia Tupone, et al.
Cancer Research
|
December 14, 2021
Targeting Chemotherapy to Decondensed H3K27me3-Marked Chromatin of AML Cells Enhances Leukemia Suppression
Patrizia Porazzi, Svetlana Petruk, Luca Pagliaroli, et al.
The Journal of Clinical Investigation
|
April 14, 2009
Targeting autophagy potentiates tyrosine kinase inhibitor-induced cell death in Philadelphia chromosome-positive cells, including primary CML stem cells
Cristian Bellodi, Maria Rosa Lidonnici, Ashley Hamilton, et al.
Neoplasia (New York, N.Y.)
|
August 21, 2012
The p53 codon 72 Pro/Pro genotype identifies poor-prognosis neuroblastoma patients: correlation with reduced apoptosis and enhanced senescence by the p53-72P isoform
Sara Cattelani, Giovanna Ferrari-Amorotti, Sara Galavotti, et al.
Journal of the National Cancer Institute
|
November 23, 2017
Targeting BCR-ABL-Independent TKI Resistance in Chronic Myeloid Leukemia by mTOR and Autophagy Inhibition
Rebecca Mitchell, Lisa E M Hopcroft, Pablo Baquero, et al.
Molecular Cancer Therapeutics
|
May 31, 2015
Structure-Based Screen Identifies a Potent Small Molecule Inhibitor of Stat5a/b with Therapeutic Potential for Prostate Cancer and Chronic Myeloid Leukemia
Zhiyong Liao, Lei Gu, Jenny Vergalli, et al.
Blood Cancer Discovery
|
September 25, 2020
Persistence of Drug-Resistant Leukemic Stem Cells and Impaired NK Cell Immunity in CML Patients Depend on <i>MIR300</i> Antiproliferative and PP2A-Activating Functions
Giovannino Silvestri, Rossana Trotta, Lorenzo Stramucci, et al.
Page
of 7